AMANDA CUBIT: Open Payments
NPI 1750882775 · ADA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$343 in 17 payments from 11 companies in 2025. Trend: 2023 $45 · 2024 $209 · 2025 $343
Food & beverage: $343
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $68 |
| Sumitomo Pharma America, Inc. | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Novo Nordisk Inc | 2 | $34 |
| PFIZER INC. | 2 | $34 |
| Lilly USA, LLC | 2 | $34 |
| Lundbeck LLC | 1 | $24 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Exact Sciences Corporation | 1 | $15 |
| SANOFI PASTEUR INC. | 1 | $15 |
Products named: QULIPTA, GEMTESA, FARXIGA, Saxenda, PREVNAR 20, MOUNJARO, REXULTI, JOURNAVX.
Industry payments across OK — which companies pay providers there.
